Leonard Arbeit is a Nephrology physician affiliated with Stony Brook School. OpenAlex indexes 21 publications with 721 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
26 Research Way
East Setauket, NY 11733
Telephone
631-444-0580Registry record last updated 8 Jul 2007.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Olympus America Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.1%Thiazide diuretic30.6%Hydrochlorothiazide100%Part D<11 patientsCalcium channel blocker22.4%Amlodipine Besylate100%Part D<11 patientsHormonal (systemic)
24.5%Calcium-sensing Receptor Agonist24.5%Cinacalcet Hcl100%Part D<11 patientsMusculoskeletal
22.4%Xanthine oxidase inhibitor22.4%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1998–1999 per NIH RePORTER. The latest:
- ROLE OF MARTRLLC METALLOPROTEINASES IN DEVELOPMENT OF DIABETIC NEPHROPATHY
State University New York Stony Brook
FY1999M01RR010710 - ROLE OF MARTRLLC METALLOPROTEINASES IN DEVELOPMENT OF DIABETIC NEPHROPATHY
State University New York Stony Brook
FY1998M01RR010710
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of Sodium Abnormalities with Outcomes in Hospitalized Patients with and Without COVID-19
Journal of the American Society of Nephrology
2021 - Comparison of Prescribed and Measured Dialysate Sodium: A Quality Improvement Project
American Journal of Kidney Diseases
2016 - Markedly Elevated Serum MMP-9 (Gelatinase B) Levels in Rheumatoid Arthritis: A Potentially Useful Laboratory Marker
Clinical Immunology and Immunopathology
1996 - Elevated levels of 92‐kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis
Arthritis & Rheumatism
1996
Similar KOLs
Other experts from the same institution or the same specialty.
Gabrielle Carlson, MD
Stony Brook School
Sharon Nachman, MD
Stony Brook School
Richard Bronson, MD
Stony Brook School
Mark Sedler, MD
Stony Brook School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”